E89R
TEAS SECTION 8 & 9 RECEIVED
08/19/2026
Back to search
Official data from USPTO
HETLIOZ SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
08/19/2026
Trademark type
Combined
Nice classes
36, 44
Filing date
04/16/2014
Registration date
06/27/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/10/2023
Last transaction
08/19/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/21/2014
First use in commerce
04/21/2014
Drawing code
3
Owner type
03
Owner location
Washington, DC, US
Examiner
I, DAVID C
Law office
M50
Current location
TMO LAW OFFICE 114
Mark description
The mark consists of the words "HETLIOZ Solutions", the word "HETLIOZ" in all capital letters, and "Solutions" italicized. To the left of "HETLIOZ Solutions", a visual representation of the letters "H" and "S" in Braille appear.
Holders and representatives
Holders
Vanda Pharmaceuticals Inc.
Representatives
Jayme M. Torelli HOFFMAN WARNICK LLC
Technical classification
Nice Classes
Class 36Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Insurance servicesinsurance eligibility review and verification and consultation in the healthcare industry; providing a database featuring information about patient reimbursement and insurance coverage for pharmaceuticals; providing health insurance claims negotiation and appeal services; and providing information about healthcare insurance plansidentifying insurance options to cover prescription drug therapy
Class 44
Patient assistance programsfinancial assistance programs to provide access to prescription drug therapy to patients with insufficient or no health insurance coverage; providing prescription drug refill reminders; and providing limited personal medical services for individualschecking medication compliance; providing medical information materialsmaterials including information on medical conditions and prescription drugs used to treat medical conditions; and providing medical information about prescription drug therapyanswers to patient questions regarding prescription drug therapy
Publications
History of USPTO decisions and trademark events.
48 publications found
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/27/2026
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/10/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/10/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/10/2023
E815
TEAS SECTION 8 & 15 RECEIVED
09/30/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/27/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/27/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/23/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/20/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/04/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/03/2017
EX3G
SOU EXTENSION 3 GRANTED
05/03/2017
IUAF
USE AMENDMENT FILED
04/20/2017
EISU
TEAS STATEMENT OF USE RECEIVED
04/20/2017
EXT3
SOU EXTENSION 3 FILED
04/19/2017
EEXT
SOU TEAS EXTENSION RECEIVED
04/19/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/08/2016
EX2G
SOU EXTENSION 2 GRANTED
11/07/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/07/2016
EXT2
SOU EXTENSION 2 FILED
10/19/2016
EEXT
SOU TEAS EXTENSION RECEIVED
10/19/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/22/2016
EX1G
SOU EXTENSION 1 GRANTED
04/20/2016
EXT1
SOU EXTENSION 1 FILED
04/20/2016
EEXT
SOU TEAS EXTENSION RECEIVED
04/20/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/20/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/25/2015
PUBO
PUBLISHED FOR OPPOSITION
08/25/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/05/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/21/2015
ALIE
ASSIGNED TO LIE
07/15/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/17/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/16/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/16/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/16/2014
GNFR
FINAL REFUSAL E-MAILED
12/16/2014
CNFR
FINAL REFUSAL WRITTEN
12/16/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/20/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/20/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/20/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/20/2014
GNRT
NON-FINAL ACTION E-MAILED
05/20/2014
CNRT
NON-FINAL ACTION WRITTEN
05/20/2014
DOCK
ASSIGNED TO EXAMINER
05/12/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/01/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/30/2014
Continuous trademark protection
Get notified about every new filing that threatens HETLIOZ SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.